J

Johnson & Johnson

Makes prescription drugs and medical devices

Global Medical Head - Early Development, Interventional Oncology

Biology & BiotechConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • An MD, DO, or equivalent is required.
  • A minimum of 8–10 years of experience in oncology within the pharmaceutical industry and/or academia is required.
  • A trained medical oncologist (board certified or eligible, or equivalent) is highly preferred; consideration would be given to a non-medical oncologist with significant development experience in solid tumor oncology.
  • Experience in early development oncology clinical research is highly preferred.
  • Experience in solid tumors specifically is highly preferred.
  • Three or more years of people management experience is required.
  • A strong track record in leadership roles, including working with senior clinical staff, establishing credible relationships with external stakeholders such as opinion leaders and regulators, and demonstrating substantial experience in drug development, including IND and NDA/BLA submissions.
  • Past experience managing study start-up, directing and guiding study teams in study execution, data cleaning, medical review, database lock, and health authority responses is needed.
  • A strong commitment to oncology/hematology clinical research and the ability to work in a matrix global team setting are required.
  • Knowledge of Good Clinical Practices and regulatory requirements for conducting high-quality oncology clinical trials is required.
  • Demonstrated ability to present scientific content to diverse audiences is required.
  • Learning agility and ability to work across multiple sectors, including pharmaceutical, medical device, and/or consumer, are required.
  • Fluency in written and spoken English is required.
  • Ability to travel up to 25% domestically and internationally.
  • An advanced additional degree (MS or PhD) is a plus.
  • Experience in protocol development, medical review, oversight of study conduct, running trials, data quality, and safety is strongly preferred.

Responsibilities

  • Define the vision, strategy, and accountability across the Interventional Oncology Early Development portfolio.
  • Provide expertise and support to clinical leaders, study responsible physicians, and clinical scientists on strategy, execution plans, product evaluation, complexity, trial cost, and safety surveillance; develop the strategy and plans for global regulatory submission and approval.
  • Work closely with functional partners in Data Management, Biostatistics, Regulatory, Engineering, Global Development, Quality, and GMS to ensure an integrated, strategic approach to execution and systematic oversight of study protocols in late development, collaborating with key functional stakeholders.
  • Maintain portfolio accountability for delivery on time and on budget throughout the life cycle, including study start-up, and direct and guide study teams in study enrollment, execution, data cleaning, medical review, database lock, and management of health authority responses.
  • Evaluate scientific information and new ideas to identify research opportunities, and support the Interventional Oncology Discovery Forum to advance the pipeline.
  • Oversee work with the Clinical Leader to support development and compilation of NDA/MAAs and responses to Health Agency questions and Health Agency presentations after filing.
  • Review or co-author medical publications emerging from clinical trial results, as needed.
  • Act as a liaison between the company and global key opinion leaders by fostering strong relationships.
  • Interact with medical consultants alongside senior clinical staff in conducting IDMC and investigator meetings and advisory boards, as needed.
  • Create a purpose-driven environment by aligning Johnson & Johnson’s Credo and Leadership Imperatives with team and enterprise strategies and goals.

Desired Qualifications

  • A trained medical oncologist (board certified or eligible, or equivalent); significant solid-tumor oncology development experience may be considered for a non-medical oncologist.
  • Experience in early development oncology clinical research.
  • Experience in solid tumors specifically.
  • An advanced additional degree (MS or PhD).
  • Experience in protocol development, medical review, oversight of study conduct, running trials, data quality, and safety.

About the Company

Johnson & Johnson

Makes prescription drugs and medical devices

Johnson & Johnson develops prescription medicines and makes medical devices for hospitals, and unlike most big drugmakers, it runs both businesses under one roof. In 2015, its Darzalex became the first antibody drug approved for multiple myeloma, a blood cancer. Its medicines treat cancer, immune diseases such as psoriasis, and mental illnesses such as depression, and patented drugs bring in most of its sales. Its MedTech unit makes heart pumps, catheters that treat irregular heartbeats, surgical sutures, and Acuvue contact lenses. It was founded in 1886 to make sterile surgical dressings, is based in New Brunswick, New Jersey, and spun off its consumer brands, such as Tylenol and Band-Aid, as Kenvue in 2023.

Company size
10,001+
Company stage
IPO
Headquarters
New Brunswick, NJ
Founded
1886

Recently Posted Jobs

Explore more opportunities at Johnson & Johnson

See more jobs